Document:

Exhibit 10.5

 

CONSULTING SERVICES AGREEMENT

 

This
CONSULTING SERVICES AGREEMENT (this “Agreement”), is made as of this 13th day of September, 2022 (“Effective
Date”), by and between Dr. Orsula V. Knowlton (“Consultant”) and Tabula Rasa Healthcare, Inc. (“Company”).

 

W I T N E S S E T H:

 

WHEREAS, Consultant previously
served as the President and Chief New Business & Marketing Officer of Company (“President”) of Company;

 

WHEREAS,
Consultant has terminated employment as the President pursuant to the terms and conditions of the Executive Transition and Separation
Agreement, effective September 13, 2022 (the “Separation Agreement”) and
Company wishes to retain Consultant to continue to provide certain consulting and advisory services as set forth in Paragraph 1 below;
and

 

WHEREAS, Consultant has agreed
to provide the consulting and advisory services on the terms and conditions set forth in this Agreement.

 

NOW, THEREFORE, in consideration
of the promises and of the mutual representations, warranties and agreements set forth herein, Consultant and Company agree as follows:

 

1.         Services.
During the Term (as defined in Paragraph 4 below), Consultant shall provide consulting and advisory services to Company’s Board
of Directors and interim Chief Executive Officer on an as needed basis at the direction of Company’s Board of Directors, including
assisting with the transition of key client relationships and strategic business partners and prospects (the “Services”).
Consultant agrees to use reasonable best efforts in connection with performing the Services under this Agreement.

 

2.         Compensation.
In exchange for the Services, Consultant shall be paid an hourly rate of $216.00 per hour, payable monthly in installments, over the
Term.

 

3.         Term and Termination. This Agreement shall commence on the Effective Date and shall automatically terminate on December
31, 2022 (the “Term”); provided, that, this Agreement may be extended by mutual agreement of the parties and may be terminable
by either party for any reason or no reason upon thirty (30) days advance written notice. The effective date of the termination set forth
in the written notice will be the “Termination Date.”

 

4.         No
Benefits; Taxes.

 

(a)        Consultant
is not an employee of Company and will not be entitled to participate in, or receive any, benefit or right as a Company employee under
any Company employee benefit and welfare plans, including, without limitation, employee insurance, pension, savings and security plans,
as a result of entering into this Agreement.

 

     

     

    

 

(b)       
Consultant shall be responsible for all estimated, withholding, social security, disability, unemployment, self-employment and
other taxes, imposed on Consultant by the federal government or any other domestic or non-domestic, federal, state, or local tax authority.

 

(c)       
Company shall reimburse Consultant for reasonable expenses associated with rendering the Services; provided, however, that Consultant
is not authorized to incur any expenses on behalf of Company without prior written consent of the Company’s Board of Directors,
and all statements submitted by Consultant for services and expenses shall be in the form prescribed by Company and shall be accompanied
by receipts for all expenses.

 

5.         Restrictive
Covenant Obligations. Consultant acknowledges and agrees that Consultant is bound by the restrictive covenants set forth in the Separation
Agreement.

 

6.         Delivery
of Records. Upon the Termination Date, Consultant shall deliver to Company all correspondence, reports, keys, ID badge, records and
any and all other documents pertaining to or containing information relative to the business of Company, and Consultant shall not remove
any of such records either during the Term or upon the Termination Date.

 

7.         No
Agency Relationship. This Agreement does not, and shall not be deemed to, make either party hereto the agent or legal representative
of the other for any purpose whatsoever. Neither party shall have the right or authority to assume or create any obligations or responsibility
whatsoever, express or implied, on behalf of or in the name of the other, or to bind the other in any respect whatsoever.

 

8.         Independent Contractor. In making and performing this Agreement, Consultant shall act at all times as an independent contractor
and nothing contained in this Agreement shall be construed or implied to create between Consultant and Company an agency, partnership,
or employee-employer relationship, or to create between Consultant and Company any other form of legal association or arrangement which
imposes liability upon one party for the act or failure to act of the other party.

 

9.         Assignment. This Agreement shall be binding upon the parties hereto, the heirs, and legal representatives of Consultant
and the successors and assigns of Company. The Consultant may not assign or otherwise transfer any of Consultant’s rights or obligations
under this Agreement without the prior written consent of Company.

 

10.       
Notices. Any notice required, permitted or intended to be given under this Agreement shall be in writing and shall be deemed
to have been given only if delivered personally or sent by registered or certified mail, return receipt requested, postage prepaid to
the appropriate address shown below, or such revised address as is delivered to the other party by the same means.

 

(a)       
Notices to Company shall be addressed to Company in care of the Chairman of the Board of Directors at the corporate headquarters
of Company.

 

(b)       
Notices to Consultant shall be sent to the most recent address on file with Company.

 

    2

     

    

 

11.       Entire Agreement. This Agreement and the Separation Agreement constitute the entire agreement between the parties in connection
with the subject matter hereof, supersedes any and all prior agreements or understandings between the parties and may only be changed
by agreement in writing between the parties.

 

12.       
Construction. This Agreement shall be construed and enforced in accordance with the laws of the State of New Jersey, without
application of the principles of conflicts of laws.

 

13.       
Counterparts; Facsimile Signatures. This Agreement may be executed in multiple counterparts, each of which shall be deemed
an original, but all of which together shall constitute one and the same instrument. Facsimile signatures shall be considered original
signatures.

 

14.       
Severability. If any provision of this Agreement is held to be invalid or unenforceable by a court of competent jurisdiction,
this Agreement shall be interpreted and enforceable as if such provision were severed or limited, but only to the extent necessary to
render such provision and this Agreement enforceable.

 

[SIGNATURE PAGE FOLLOWS]

 

    3

     

    

 

IN WITNESS WHEREOF, and intending
to be legally bound, the parties have executed this Agreement the day and year first above written.

 

	 	Tabula Rasa Healthcare, Inc.
	 	 
	 	By:	/s/ Brian W. Adams
	 	 	Name: Brian W. Adams
	 	 	Title: Interim Chief Executive Officer
	 	 
	 	Dr. Orsula V. Knowlton
	 	 
	 	/s/ Orsula V. Knowlton

 

    4EX-4.1

 Exhibit 4.1 

EXECUTION VERSION 

AMENDMENT NO. 7 

AMENDMENT NO. 7 TO THE AMENDED AND RESTATED CREDIT AGREEMENT, dated as of September 14, 2022 (this
“Amendment”), among THE SHERWIN-WILLIAMS COMPANY, an Ohio corporation (the “Company”), the Lenders party hereto, GOLDMAN SACHS BANK USA (“GS Bank”), as Administrative Agent (in
such capacity, the “Administrative Agent”), and GOLDMAN SACHS MORTGAGE COMPANY (“GSMC”), as Issuing Bank (in such capacity, the “Issuing Bank”). Capitalized terms not otherwise
defined in this Amendment have the same meanings as specified in the Credit Agreement referred to below. 
 PRELIMINARY STATEMENTS:

 (1) The Company, the Administrative Agent, the Lenders from time to time party thereto and the Issuing Bank are parties to that
certain Amended and Restated Credit Agreement, dated as of August 2, 2021 (as amended by Amendment No. 1 to the Amended and Restated Credit Agreement, dated as of August 6, 2021, Amendment No. 2 to the Amended and Restated Credit
Agreement, dated as of November 18, 2021, Amendment No. 3 to the Amended and Restated Credit Agreement, dated as of November 30, 2021, Amendment No. 4 to the Amended and Restated Credit Agreement, dated as of August 15,
2022, Amendment No. 5 to the Amended and Restated Credit Agreement, dated as of August 26, 2022, and Amendment No. 6 to the Amended and Restated Credit Agreement, dated as of September 8, 2022, the “Existing
Credit Agreement”; the Existing Credit Agreement as amended by this Amendment, the “Credit Agreement”). 

(2) The Company has requested, and the Administrative Agent and the Lenders have agreed, on the terms and conditions set forth herein, to amend
the Existing Credit Agreement as specified herein. 
 NOW, THEREFORE, in consideration of the premises and for other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows: 
 SECTION 1.
Amendments to the Existing Credit Agreement. Upon, and subject to, the satisfaction (or waiver in accordance with Section 9.02 of the Existing Credit Agreement) of the conditions precedent set forth in Section 2 below, the Existing
Credit Agreement is hereby amended as follows: 
 (a) The following new definition is included in Section 1.01 of the
Existing Credit Agreement in the proper alphabetical order as follows: 
 ““Amendment
No. 7 Effective Date” means September 14, 2022.” 

  

					
		 	1	 	 THE SHERWIN-WILLIAMS COMPANY

Amendment No. 7 to Credit Agreement

 (b) Each of the following definitions in Section 1.01 of the Existing
Credit Agreement is hereby amended and restated in its entirety as follows: 
 ““Commitment”
means, with respect to each Lender, the commitment of such Lender to acquire participations in the Letter of Credit and to make Loans, as such commitment may be (a) reduced from time to time pursuant to Section 2.07, (b) reduced or
increased from time to time pursuant to assignments by or to such Lender pursuant to Section 9.04 or (c) reduced or increased from time to time pursuant to an amendment hereto. The amount of each Lender’s Commitment on the Amendment
No. 7 Effective Date is set forth on Schedule 2.01, or in the Assignment and Acceptance pursuant to which such Lender shall have assumed its Commitment, as applicable.” 

““Maturity Date” means December 20, 2026; provided, however, that
(i) with respect to the Commitments in the aggregate principal amount of $125,000,000, the Maturity Date shall mean June 20, 2023, (ii) with respect to the Commitments in the aggregate principal amount of $75,000,000, the Maturity Date
shall mean June 20, 2025, (iii) with respect to the Commitments in the aggregate principal amount of $200,000,000, the Maturity Date shall mean June 20, 2026, and (iv) with respect to the Commitments in the aggregate principal amount
of $225,000,000, the Maturity Date shall mean December 20, 2026.” 
 (c) Schedule 2.01 of the Existing Credit
Agreement is hereby amended and restated in its entirety as set forth in Schedule 2.01 attached hereto. 
 SECTION 2. Conditions of
Effectiveness. This Amendment shall become effective on the date (the “Amendment No. 7 Effective Date”) on which: 

(a) the Administrative Agent shall have received a counterpart signature page of this Amendment duly executed by (i) the
Company, (ii) the Administrative Agent, (iii) the Lenders, and (iv) the Issuing Bank or, as to any of the foregoing parties, written evidence reasonably satisfactory to the Administrative Agent that such party has executed this
Amendment; 
 (b) the Administrative Agent shall have received one or more counterparts of the Eighth Amended and Restated
Letter Agreement, dated as of the date hereof, duly executed by the Company and GSMC; and 
 (c) the representations and
warranties set forth in Section 4 of this Amendment shall be true and correct in all respects. 
 SECTION 3. Effect of this
Amendment, Etc. 
 (a) Except as expressly set forth herein, this Amendment shall not by implication or otherwise limit,
impair, constitute a waiver of, or otherwise affect the rights and remedies of the Issuing Bank, the Lenders or the Administrative Agent under the Credit Agreement or any other Loan Document, and shall not alter, modify, amend or in any way affect
any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other Loan Document, all of which are ratified and affirmed in all respects and shall continue in full force and effect. 

(b) Nothing herein shall be deemed to entitle the Company to a consent to, or a waiver, amendment, modification or other change
of, any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other Loan Document in similar or different circumstances. 

  

					
		 	2	 	 THE SHERWIN-WILLIAMS COMPANY

Amendment No. 7 to Credit Agreement

 (c) After the Amendment No. 7 Effective Date, each reference in any
Loan Document to the Credit Agreement, to “this Agreement”, “hereunder”, “hereof” or words of like import referring to the Credit Agreement, shall mean and be a reference to the Existing Credit Agreement, as modified
hereby. This Amendment shall constitute a “Loan Document” for all purposes of the Credit Agreement and the other Loan Documents. 

SECTION 4. Representations and Warranties. The Company represents and warrants to the Administrative Agent and the Lenders that, on and
as of the date hereof and on and as of the Amendment No. 7 Effective Date: 
 (a) (i) The execution, delivery and
performance by the Company of this Amendment and the transactions contemplated hereby have been duly authorized by all necessary corporate action, and (ii) this Amendment has been duly executed and delivered by the Company and constitutes a
legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as may be limited by applicable bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium or similar laws of
general applicability relating to or affecting creditors’ rights generally and subject to general principals of equity, regardless of whether considered in a proceeding in equity or at law. 

(b) The representations and warranties of the Company contained in the Credit Agreement and any other Loan Document are true
and correct in all material respects, except to the extent such representations and warranties expressly relate to an earlier date (in which case such representations and warranties are true and correct in all material respects as of such earlier
date). 
 (c) Both before and after giving effect to this Amendment, no Default or Event of Default has occurred and is
continuing. 
 SECTION 5. Execution in Counterparts. This Amendment may be executed in counterparts (and by different parties hereto
on different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract, it being understood and agreed that the words “execution,” “signed,”
“signature,” and words of similar import in, or with respect to, this Amendment shall be deemed to include electronic signatures or the keeping of records in electronic form (including, without limitation, the execution by means of
“DocuSign”, or other similar platform or service approved by the Administrative Agent), each of which shall be of the same effect, validity and enforceability as manually executed signatures or a paper-based recordkeeping system, as the
case may be, to the extent and as provided for under applicable law, including the Electronic Signatures in Global and National Commerce Act of 2000 (15 USC § 7001 et seq.), the Electronic Signatures and Records Act of 1999 (NY State Technology
Law §§ 301-309), or any other similar state laws based on the Uniform Electronic Transactions Act; provided, that any electronic signature delivered by means of “DocuSign”, or other similar
third-party platform by one party shall be at the request of any other party hereto promptly followed by an email attestation by such party to the recipient party confirming that such electronic signature so delivered is the signature of such party;
provided, further, that upon the request of the Administrative Agent, any electronic signature shall be followed by a manually executed counterpart as promptly as reasonably practicable. 

  

					
		 	3	 	 THE SHERWIN-WILLIAMS COMPANY

Amendment No. 7 to Credit Agreement

 SECTION 6. Governing Law. This Amendment shall be governed by, and construed in
accordance with, the laws of the State of New York. 
 SECTION 7. WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES, TO THE
FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AMENDMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY (WHETHER BASED ON CONTRACT, TORT
OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE
FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION. 

SECTION 8. Jurisdiction; Consent to Service of Process. 

(a) The Company hereby irrevocably and unconditionally submits, for itself and its property, to the nonexclusive jurisdiction of the Supreme
Court of the State of New York sitting in New York County and of the United States District Court of the Southern District of New York, and any appellate court from any thereof, in any suit, action or proceeding arising out of or
relating to this Amendment, or for recognition or enforcement of any judgment, and each of the parties hereto hereby irrevocably and unconditionally agrees that all claims in respect of any such suit, action or proceeding may be heard and determined
in such New York State or, to the extent permitted by law, in such Federal court. Each of the parties hereto agrees that a final judgment in any such suit, action or proceeding shall be conclusive and may be enforced in other jurisdictions by
suit on the judgment or in any other manner provided by law. Nothing in this Amendment shall affect any right that the Administrative Agent or any Lender or the Issuing Bank may otherwise have to bring any suit, action or proceeding relating to this
Amendment against the Company or its properties in the courts of any jurisdiction. 
 (b) The Company hereby irrevocably and unconditionally
waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Amendment in any court referred to in
subsection (b) of this Section. Each of the parties hereto hereby irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court. 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

  

					
		 	4	 	 THE SHERWIN-WILLIAMS COMPANY

Amendment No. 7 to Credit Agreement

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by
their respective officers thereunto duly authorized, as of the date first above written. 
  

			
	THE SHERWIN-WILLIAMS COMPANY
		
	By:	 	 /s/ Jeffrey J. Miklich

		 	Name: Jeffrey J. Miklich
		 	Title: Vice President and Treasurer

  

					
		 		 	 THE SHERWIN-WILLIAMS COMPANY

Amendment No. 7 to Credit Agreement

 
			
	GOLDMAN SACHS BANK USA,
	as Administrative Agent and as Lender
		
	By:	 	 /s/ William E. Briggs IV

		 	Name: William E. Briggs IV
		 	Title: Authorized Signatory

  

					
		 		 	 THE SHERWIN-WILLIAMS COMPANY

Amendment No. 7 to Credit Agreement

 
			
	GOLDMAN SACHS MORTGAGE COMPANY,
	as Issuing Bank
		
	By:	 	 /s/ Thomas Manning

		 	Name: Thomas Manning
		 	Title: Authorized Signatory

  

					
		 		 	 THE SHERWIN-WILLIAMS COMPANY

Amendment No. 7 to Credit Agreement

 SCHEDULE 2.01 

To 
 Credit Agreement

 Commitments 
  

			
	 Lender
	  	 Commitment

	 Goldman Sachs Bank USA
	  	$625,000,000.00
	 Total:
	  	$625,000,000.00

 (continued below) 

Scheduled Reductions in the Aggregate Commitments 
  

			
	Aggregate Scheduled Reduction ($) in the Total Commitment(s) and
Commitment of the Issuing Bank (without duplication)	  	Date on Which Scheduled Reduction Takes Effect
	 $125,000,000
	  	June 20, 2023
	 $75,000,000
	  	June 20, 2025
	 $200,000,000
	  	June 20, 2026
	 $225,000,000
	  	December 20, 2026

  

					
		 	Schedule 2.01 – 1	 	 THE SHERWIN-WILLIAMS COMPANY

Amendment No. 7 to Credit Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}]]